Michelle Burk
Women's Health · Chesterfield, MONPI 1174607618
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $877 and has fallen 72.6% since, to $240 in 2025. Among women's health clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 179 payments — averaging $16.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$580
- AbbVie$547
- Evofem Biosciences, Inc.$288
- Myovant Sciences Inc.$223
- Organon$212
- Astellas Pharma US Inc$173
- plus $997 from 19 others
What the payments were for
- Food & beverage$3,020100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 40 | $580 |
| AbbVie | 32 | $547 |
| Evofem Biosciences, Inc. | 15 | $288 |
| Myovant Sciences Inc. | 11 | $223 |
| Organon | 15 | $212 |
| Astellas Pharma US Inc | 9 | $173 |
| Exeltis, USA Inc. | 9 | $152 |
| Sumitomo Pharma America, Inc. | 7 | $145 |
| Avion Pharmaceuticals | 6 | $110 |
| Amgen | 6 | $106 |
| Bayer | 6 | $96 |
| Merck | 4 | $65 |
| Therapeuticsmd, Inc. | 4 | $52 |
| Daiichi Sankyo Inc. | 2 | $41 |
| Pfizer | 2 | $32 |
| Coopersurgical, Inc. | 1 | $26 |
| Dexcom, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $26 |
| Ascend Therapeutics US, LLC | 2 | $25 |
| Agile Therapeutics, Inc. | 1 | $18 |
| Novo Nordisk | 1 | $18 |
| Exact Sciences | 1 | $17 |
| Optumhealth Care Solutions, LLC | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Lupin Inc. | 1 | $11 |
How this compares
$3,020 in reported general payments places this provider in the 90th percentile of 208 women's health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 28 | $2,745 |
| Fluconazole | 16 | $83 |
Paid to pharmacies, not to this prescriber.
Other women's health in Chesterfield
- Jesica CampbellChesterfield$2K
- Angela HallChesterfield$2K
- Heather SiebersChesterfield$2K
- Kathryn SimoneBlue Springs$192K
- Nealya Bell-SilvaSaint Louis$107K
- Susan HoffstetterSaint Louis$39K
- Karla WilmotIndependence$22K
- Janice EislebenSaint Louis$16K
- Susan Mitchell-DerenskiSaint Louis$14K
- Amanda SchillySaint Louis$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.